淫羊藿苷
化学
溶剂
立体化学
传统医学
有机化学
医学
替代医学
病理
作者
Jianping Hu,Lingling Song,Le Zhao,Yang Fu,Weisheng Feng,Haoyu Jia
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2025-07-03
卷期号:30 (13): 2847-2847
标识
DOI:10.3390/molecules30132847
摘要
Icariside I, a bioactive flavonoid derivative derived from Herba epimedii, demonstrates better pharmacological properties compared to its precursor icariin. Enzymatic conversion of icariin to icariside I using α-L-rhamnosidase represents an efficient biotechnological approach. In this study, we characterized a GH78 family α-L-rhamnosidase from Dictyoglomus thermophilum (DthRha) with promising biocatalytic properties. The recombinant DthRha displayed optimal activity at 55 °C and pH 6.0, with remarkable thermostability (retaining > 80% activity after 1 h at 45-65 °C) and pH stability (pH 5.0-7.0). The kinetic parameters Km, kcat and kcat/Km values for pNPR of 0.44 mM, 7.99 s-1 and 18.16 s-1 mM-1, respectively. Notably, DthRha exhibited good organic solvent tolerance, retaining > 50% activity after 4 h in 10% DMSO. Applied in a DMSO cosolvent system, DthRha achieved 92.3% conversion of icariin to icariside I within 4 h under optimized conditions. Interestingly, elevating the substrate concentration to 10 mM resulted in a consistently high icariin conversion of 95.8%. The enzymatic hydrolysis method can be applied to the industrial production of Icariside I. Furthermore, DthRha not only cleaves the α-1,2 glycosidic bond between glucoside and rhamnoside in compounds like naringin, but also exhibits tolerance to organic solvents, making it suitable for the hydrolysis of other poorly soluble flavonoids.
科研通智能强力驱动
Strongly Powered by AbleSci AI